Skip to main content
Signal8

PURPLE BIOTECH LTD. (PPBT)

Purple Biotech Ltd., a clinical-stage biotechnology firm based in Rehovot, Israel, is dedicated to pioneering treatments that help cancer patients, particularly in the United States, overcome tumor immune evasion and drug resistance. Its pipeline features two primary oncology assets: CM24: A monoclonal antibody designed to block carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1). This candidate is undergoing Phase 1b/2 clinical trials, where it is being evaluated as a combination therapy with anti-PD-1 checkpoint inhibitors for non-small cell lung cancer and pancreatic cancer. NT219: A small molecule compound that targets insulin receptor substrate 1 and 2 (IRS1/2) as well as signal transducer and activator of transcription (STAT) pathways. NT219 is currently in Phase 1/2 clinical studies for the treatment of recurrent or metastatic solid tumors and squamous cell carcinoma of the head and neck. The company was formerly known as Kitov Pharma Ltd until its rebranding to Purple Biotech Ltd. in December 2020.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Purple Biotech Ltd. logo

Purple Biotech Ltd.

NASDAQ:PPBTHealthcare
+7.34%$1.17
Mkt Cap$1.9M
Float1.6M
O/S1.63M
Vol
$ Vol
RVOL
Inst Own6.6%
SI1.0%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$26.39M
Total Assets$17.57M
Free Cash Flow-$5.54M
Debt & Equity
Debt 2%
Equity 98%
Total Debt$244K
Total Equity$9.71M
Shares Outstanding
Short Interest
Split History3 splits · 3 reverse
2-year cumulative
1:10

Nasdaq bars a compliance period at 1:250

  1. 1:10Reverse split
    Mar 2, 202610 shares → 1
  2. 1:20Reverse split
    Sep 17, 202420 shares → 1
  3. 1:10Reverse split
    Aug 21, 202010 shares → 1
Balance Sheet Details
Assets$17.57M
Liabilities$7.91M
Accounts Receivable$155K
Accounts Payable$2.07M
Inventory$0
PP&E (Net)$346K
Goodwill$0
Intangible Assets$7.36M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue$0$0$0$0$0$0$1M$1M$100K$0$0$0$0
YoY Growth------0.0%900.0%-----
Cost of Revenue$0$0$0$0$0$237K$80$0$0$0$0$0$0
Gross Profit$0$0$0$0$0-$237K$1M$1M$100K$0$0$0$0
Gross Margin------100.0%100.0%100.0%----
Research and Development$3.73M$7.62M$17.03M$16.32M$11.83M$7.29M$2.28M$5.27M$4.64M$4.18M$2.56M$3.19M$109K
Selling, General, and Administrative$2.98M$2.94M$4.84M$5.96M$5.82M$5.81M$6.08M$5.19M$6.39M$3M$1.51M$1.27M$1.06M
Other$20.74M$450K$393K$321K$286K$1$356K$0$1.03M$0$0$0$0
Total Operating Expenses$27.46M$11.01M$22.27M$22.6M$17.93M$13.1M$8.75M$8.83M$12.06M$7.18M$4.07M$5.18M$1.17M
Operating Income (EBIT)-$27.46M-$11.01M-$22.27M-$22.6M-$17.93M-$13.33M-$7.16M-$7.83M-$11.97M-$7.18M-$4.07M-$5.18M-$2.55M
Operating Margin-------715.6%-782.6%-11966.0%----
Interest Expense$39K$41K$56K$67K$79K$56K$181K$9K$26K$6K$3K$21K$48K
Interest Income$227K$260K$474K$532K$320K$256K$151K$93K$106K$138K$94K$0$0
Other Income (Expense)$966K$3.73M$2.29M$843K$108K-$15.57M$1.48M$2.26M-$1.04M-$4.94M-$133K-$71K-$75K
Income Before Tax (EBT)-$26.49M-$7.28M-$19.98M-$21.76M-$17.83M-$28.9M-$5.89M-$5.57M-$12.91M-$12.13M-$4.2M-$5.25M-$2.63M
Income Tax Expense$0$0$0$0$0$0$216K$0$0$6K$0$0$0
Net Income-$26.39M-$7.24M-$19.88M-$21.67M-$18.38M-$28.2M-$5.85M-$5.2M-$12.18M-$12.13M-$4.2M-$5.25M-$2.63M
Net Income Margin-------585.0%-520.0%-12177.0%----
Supplementary Data
EPS-5.50-4.42-17.96-24.00-20.00-50.00-56.00-74.00-258.00-422.00-874.00-4688.00-6406.00
Diluted EPS-5.50-4.42-17.96-24.00-20.00-50.00-56.00-74.00-258.00-422.00-874.00-4688.00-6406.00
Weighted Average OS4.80M1.64M1.11M902,830910,185562,410105,59071,02547,28028,7754,8101,120410
EBITDA-$26.25M-$7.05M-$19.72M-$21.49M-$17.52M-$13.1M-$6.14M-$5.55M-$12.88M-$7.04M-$4.2M-$4.46M-$1.2M
EBITDA Margin-------613.6%-555.3%-12883.0%----
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Assets
Current Assets
Cash and Cash Equivalents$8.72M$7.4M$14.49M$15.03M$10.89M$11.25M$4.38M$5.16M$3.95M$6.76M$10.56M$1.31M$193K
Short-Term Investments$857K$1.12M$923K$17.08M$36.31M$46.56M$2.01M$0$0$7.9M$0$0$0
Cash and Short-Term Investments$9.57M$8.52M$15.41M$32.11M$47.2M$57.8M$6.39M$5.16M$3.95M$14.66M$10.56M$1.31M$193K
Accounts Receivable$155K$275K$205K$0$0$500K$1.49M$743K$0$0$0$0$0
Inventory$0$0$0$0$0$0-$1.49M$778K$0-$7.81M-$124K-$420K$0
Other Current Assets$137K$109K-$34K$146K$268K$197K$2.18M$824K$337K$0$0$0$38K
Total Current Assets$9.87M$8.91M$15.79M$33.26M$48.47M$59.28M$8.3M$8.51M$7.98M$14.9M$10.8M$1.76M$311K
Long-Term Assets
Property, Plant & Equipment Net$346K$288K$470K$682K$896K$968K$244K$37K$28K$16K$8K$0$0
Goodwill$0$0$0$20.66M$20.46M$20.46M$0$0$0$0$0$0$0
Intangible Assets$7.36M$27.84M$28.04M$21K$20K$20K$6.17M$6.17M$6.17M$0$0$0$0
Long-Term Investments$0$0$0$0$187K$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$160K$3.07M$0$0$0$0$0$0$0
Total Long-Term Assets$7.71M$28.13M$28.51M$21.37M$21.73M$24.52M$6.42M$6.21M$6.2M$16K$8K$0$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$17.57M$37.04M$44.3M$54.62M$70.2M$83.8M$14.72M$14.72M$14.18M$14.91M$10.81M$1.76M$311K
Liabilities
Current Liabilities
Accounts Payable$2.07M$1.46M$3.53M$2.13M$1.47M$1.2M$1.25M$705K$215K$515K$353K$500K$54K
Short-Term Debt$0$0$0$0$0$0$0$0$0$0$0$294K$897K
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$961K$0$95K$0$0-$294K$0
Other Current Liabilities$4.41M$1.15M$2.52M$698K$611K$584K$1.58M$721K$2.27M$682K$690K$160K$0
Total Current Liabilities$7.75M$3.99M$9.7M$7.06M$4.25M$3.1M$3.54M$3.31M$4.07M$1.27M$1.2M$986K$1.26M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$160K$140K$141K$145K$292K$265K$285K$405K$1.52M$256K$185K$0$0
Total Long-Term Liabilities$160K$140K$304K$466K$842K$953K$313K$405K$1.52M$256K$185K$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$7.91M$4.13M$10.01M$7.52M$5.09M$4.05M$3.86M$3.72M$5.59M$1.53M$1.38M$986K$1.26M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$0$0$0$0$0$0$0$0$0$0$0$0$0
Retained Earnings-$171.08M-$144.69M-$137.45M-$117.58M-$95.91M-$77.52M-$49.52M-$43.67M-$38.57M-$26.2M-$14.05M-$9.85M-$4.6M
Comprehensive Income & Other$28.31M-$98K-$79K$38.08M$36.78M$38M$12.96M$1.62M$2.49M$1.34M$1.3M$1.32M$1M
Other Stockholders' Equity$180.79M$177.55M$171.66M$164.49M$160.73M$156.91M$59.94M$54.2M$45.88M$39.59M$23.48M$10.63M$3.65M
Total Equity$9.71M$32.86M$34.21M$46.91M$64.83M$79.39M$10.42M$10.52M$7.31M$13.38M$9.43M$773K-$946K
Minority Interest-$55K$51K$90K$187K$279K$363K$438K$481K$1.28M$0$0$0$0
Total Liabilities and Equity$17.63M$36.99M$44.21M$54.44M$69.92M$83.44M$14.28M$14.24M$12.9M$14.91M$10.81M$1.76M$311K
Supplementary Data
Total Debt$244K$183K$351K$515K$749K$895K$223K$0$0$0$0$294K$897K
Net Debt-$8.47M-$7.22M-$14.14M-$14.52M-$10.14M-$10.35M-$4.16M-$5.16M-$3.95M-$6.76M-$10.56M-$1.02M$704K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Operating Activities
Net Income-$26.39M-$7.28M-$19.88M-$21.76M-$17.83M-$28.07M-$5.89M-$5.57M-$13.01M-$12.13M-$4.2M-$5.25M-$2.63M
Depreciation & Amortization$203K$186K$197K$201K$231K$235K$179K$7K$4K$2K$1K$0$0
Deferred Income Tax$0$0$0$0$0$0$0-$894K$0$0$0$0$0
Stock-Based Compensation$309K$582K$1.88M$2.41M$2.08M$2.65M$1.27M$773K$2.31M$400K$59K$88K$296K
Changes in Working Capital:
  Accounts Receivable$154K$0$0$313K-$316K$501K$2K-$1.11M$0$0$197K-$375K-$110K
  Inventory$0$0$0$2.13M$0-$511K-$2K$0$0$0$54K$0$0
  Accounts Payable$454K-$2.08M$1.33M$799K$399K-$2.33M$503K$393K-$491K-$138K-$152K$453K-$11K
  Other Working Capital$207K-$2.26M-$1.06M$11K$661K-$20K-$163K-$933K$613K$407K$239K-$583K$255K
Total Working Capital Change$814K-$4.33M$274K$3.25M$744K-$2.36M$340K-$540K$122K$269K$284K-$130K$134K
Other Non-Cash Items$19.52M-$3.52M-$2.39M-$843K-$482K$15.46M-$1.48M-$2.26M$1.95M$5.19M$550K$768K$1.69M
Net Cash from Operating-$5.54M-$14.37M-$19.93M-$16.73M-$15.25M-$12.09M-$5.58M-$8.48M-$8.63M-$6.26M-$3.31M-$4.53M-$512K
Investing Activities
Capital Expenditures-$3K$0-$3K-$228K-$115K-$156K-$11K-$16K-$13K-$10K-$9K$0$0
Acquisitions$0$0-$3.55M$0$0$69K$0$0-$1.73M$0$0$0$0
Purchases of Investments$0$0$0$0$0-$49.62M-$2.1M$0$0-$7.9M$0$0$0
Sales of Investments$453K$189K$16.68M$19.82M$13.16M$41K$1.51M$0$0$0$0$0$0
Other Investing Activities$0$320K$755K$324K$359K$69K$151K$2.06M$4.52M-$7.9M$0$0$0
Net Cash from Investing$450K$509K$13.88M$19.91M$13.41M-$49.59M-$449K$2.04M$2.77M-$7.91M-$9K$0$0
Financing Activities
Debt Repaid$217K$183K$168K$165K$153K$179K$171K-$130K-$294K$736K-
Common Stock Issuance$6.63M$5.81M$1.56M$1.5M$1.76M$27.93M$2.59M$4.68M$2.42M$6.29M$14.94M$6.85M$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0-$341K$0$0
Other Financing Activities-$2K$1.15M$4.05M-$219K-$99K$40.74M$2.81M$3.1M$576K$4M-$1.97M-$1.03M$15K
Net Cash from Financing$6.41M$6.77M$5.45M$1.11M$1.51M$68.49M$5.23M$7.79M$3M$10.42M$12.63M$5.82M$701K
Forex Effect-$4K-$4K$54K-$153K-$24K$61K$19K-$136K$49K-$53K-$70K-$176K$4K
Net Change in Cash$1.32M-$7.09M-$541K$4.14M-$357K$6.86M-$778K$1.22M-$2.81M-$3.8M$9.24M$1.12M$193K
Supplementary Data
Operating Cash Flow-$5.54M-$14.37M-$19.93M-$16.73M-$15.25M-$12.09M-$5.58M-$8.48M-$8.63M-$6.26M-$3.31M-$4.53M-$512K
Capital Expenditure-$3K$0-$3K-$228K-$115K-$156K-$11K-$16K-$13K-$10K-$9K$0$0
Free Cash Flow-$5.54M-$14.37M-$19.93M-$16.96M-$15.37M-$12.25M-$5.59M-$8.5M-$8.64M-$6.27M-$3.32M-$4.53M-$512K
Cash at Beginning$7.4M$14.49M$15.03M$10.89M$11.25M$4.38M$5.16M$3.95M$6.76M$10.56M$1.31M$193K$0
Cash at End$8.72M$7.4M$14.49M$15.03M$10.89M$11.25M$4.38M$5.16M$3.95M$6.76M$10.56M$1.31M$193K